195 related articles for article (PubMed ID: 28385574)
21. Reversed polarity of Na(+) -K(+) -ATPase: mislocation to apical plasma membranes in polycystic kidney disease epithelia.
Wilson PD; Sherwood AC; Palla K; Du J; Watson R; Norman JT
Am J Physiol; 1991 Mar; 260(3 Pt 2):F420-30. PubMed ID: 1848046
[TBL] [Abstract][Full Text] [Related]
22. Beta4 integrin and laminin 5 are aberrantly expressed in polycystic kidney disease: role in increased cell adhesion and migration.
Joly D; Morel V; Hummel A; Ruello A; Nusbaum P; Patey N; Noël LH; Rousselle P; Knebelmann B
Am J Pathol; 2003 Nov; 163(5):1791-800. PubMed ID: 14578180
[TBL] [Abstract][Full Text] [Related]
23. cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway.
Yamaguchi T; Pelling JC; Ramaswamy NT; Eppler JW; Wallace DP; Nagao S; Rome LA; Sullivan LP; Grantham JJ
Kidney Int; 2000 Apr; 57(4):1460-71. PubMed ID: 10760082
[TBL] [Abstract][Full Text] [Related]
24. Polycystin-1 and Gα12 regulate the cleavage of E-cadherin in kidney epithelial cells.
Xu JX; Lu TS; Li S; Wu Y; Ding L; Denker BM; Bonventre JV; Kong T
Physiol Genomics; 2015 Feb; 47(2):24-32. PubMed ID: 25492927
[TBL] [Abstract][Full Text] [Related]
25. Impaired tubulogenesis of cyst-derived cells from autosomal dominant polycystic kidneys.
Carone FA; Nakamura S; Bacallao R; Nelson WJ; Khokha M; Kanwar YS
Kidney Int; 1995 Mar; 47(3):861-8. PubMed ID: 7752585
[TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor-β inhibits cystogenesis in human autosomal dominant polycystic kidney epithelial cells.
Elberg D; Jayaraman S; Turman MA; Elberg G
Exp Cell Res; 2012 Aug; 318(13):1508-16. PubMed ID: 22504005
[TBL] [Abstract][Full Text] [Related]
27. Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.
Chen L; Zhou X; Fan LX; Yao Y; Swenson-Fields KI; Gadjeva M; Wallace DP; Peters DJ; Yu A; Grantham JJ; Li X
J Clin Invest; 2015 Jun; 125(6):2399-412. PubMed ID: 25961459
[TBL] [Abstract][Full Text] [Related]
28. Compromised cytoarchitecture and polarized trafficking in autosomal dominant polycystic kidney disease cells.
Charron AJ; Nakamura S; Bacallao R; Wandinger-Ness A
J Cell Biol; 2000 Apr; 149(1):111-24. PubMed ID: 10747091
[TBL] [Abstract][Full Text] [Related]
29. Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid.
Nichols MT; Gidey E; Matzakos T; Dahl R; Stiegmann G; Shah RJ; Grantham JJ; Fitz JG; Doctor RB
Hepatology; 2004 Oct; 40(4):836-46. PubMed ID: 15382115
[TBL] [Abstract][Full Text] [Related]
30. Anion secretion drives fluid secretion by monolayers of cultured human polycystic cells.
Mangoo-Karim R; Ye M; Wallace DP; Grantham JJ; Sullivan LP
Am J Physiol; 1995 Sep; 269(3 Pt 2):F381-8. PubMed ID: 7573487
[TBL] [Abstract][Full Text] [Related]
31. Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys.
Yamaguchi T; Nagao S; Wallace DP; Belibi FA; Cowley BD; Pelling JC; Grantham JJ
Kidney Int; 2003 Jun; 63(6):1983-94. PubMed ID: 12753285
[TBL] [Abstract][Full Text] [Related]
32. Apico-basal polarity in polycystic kidney disease epithelia.
Wilson PD
Biochim Biophys Acta; 2011 Oct; 1812(10):1239-48. PubMed ID: 21658447
[TBL] [Abstract][Full Text] [Related]
33. Berberine slows cell growth in autosomal dominant polycystic kidney disease cells.
Bonon A; Mangolini A; Pinton P; Del Senno L; Aguiari G
Biochem Biophys Res Commun; 2013 Nov; 441(3):668-74. PubMed ID: 24184483
[TBL] [Abstract][Full Text] [Related]
34. Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD).
Lanoix J; D'Agati V; Szabolcs M; Trudel M
Oncogene; 1996 Sep; 13(6):1153-60. PubMed ID: 8808689
[TBL] [Abstract][Full Text] [Related]
35. Ketamine Increases Permeability and Alters Epithelial Phenotype of Renal Distal Tubular Cells via a GSK-3β-Dependent Mechanism.
Shyu HY; Ko CJ; Luo YC; Lin HY; Wu SR; Lan SW; Cheng TS; Hu SH; Lee MS
J Cell Biochem; 2016 Apr; 117(4):881-93. PubMed ID: 26365534
[TBL] [Abstract][Full Text] [Related]
36. Disruption of β-catenin/CBP signaling inhibits human airway epithelial-mesenchymal transition and repair.
Moheimani F; Roth HM; Cross J; Reid AT; Shaheen F; Warner SM; Hirota JA; Kicic A; Hallstrand TS; Kahn M; Stick SM; Hansbro PM; Hackett TL; Knight DA
Int J Biochem Cell Biol; 2015 Nov; 68():59-69. PubMed ID: 26315281
[TBL] [Abstract][Full Text] [Related]
37. Basolateral chloride transporters in autosomal dominant polycystic kidney disease.
Lebeau C; Hanaoka K; Moore-Hoon ML; Guggino WB; Beauwens R; Devuyst O
Pflugers Arch; 2002 Sep; 444(6):722-31. PubMed ID: 12355171
[TBL] [Abstract][Full Text] [Related]
38. Coexpression of extracellular matrix glycoproteins undulin and tenascin in human autosomal dominant polycystic kidney disease.
Klingel R; Ramadori G; Schuppan D; Knittel T; Meyer zum Büschenfelde KH; Köhler H
Nephron; 1993; 65(1):111-8. PubMed ID: 7692313
[TBL] [Abstract][Full Text] [Related]
39. Transcriptome analysis reveals manifold mechanisms of cyst development in ADPKD.
de Almeida RM; Clendenon SG; Richards WG; Boedigheimer M; Damore M; Rossetti S; Harris PC; Herbert BS; Xu WM; Wandinger-Ness A; Ward HH; Glazier JA; Bacallao RL
Hum Genomics; 2016 Nov; 10(1):37. PubMed ID: 27871310
[TBL] [Abstract][Full Text] [Related]
40. Anticystogenic activity of a small molecule PAK4 inhibitor may be a novel treatment for autosomal dominant polycystic kidney disease.
Hwang VJ; Zhou X; Chen X; Trott J; Abu Aboud O; Shim K; Dionne LK; Chmiel KJ; Senapedis W; Baloglu E; Mahjoub MR; Li X; Weiss RH
Kidney Int; 2017 Oct; 92(4):922-933. PubMed ID: 28545714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
